Pratia Poznan

Poznan 60-192

1 studies enrolling now · 2 studies all time

What they study most

Metastatic HER2-positive Breast Cancer, Primary Sjogrens Disease

Studies at this site

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
• A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling